Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. north america
  4. fever vomiting
Show results for
Products
Applications

Companies


Refine by
Locations
Back to All Locations

  • North America
Brands

  • brineura
  • quidel
  • vimizim

Fever Vomiting Equipment Supplied In North America

3 equipment items found
In North AmericaAvailable In North AmericaNear North America

Quidel - Campylobacter

Quidel - Campylobacter

Manufactured by:Quidel Corporation   based inSan Diego, CALIFORNIA (USA)
Worldwide, Campylobacter species are the most common cause of bacterial gastroenteritis, with 400-500 million cases of diarrhea each year.1 Infants in developing countries are at even greater risk, as are travelers to those countries.2 Campylobacter–associated gastroenteritis is estimated to affect nearly one million people a year in the U.S.3 In approximately 1 of 1000 cases, Campylobacter ...
CONTACT SUPPLIER

Vimizim - Model MPS IVA - Elosulfase Alfa for Morquio A Syndrome

Vimizim - Model MPS IVA - Elosulfase Alfa for Morquio A Syndrome

Manufactured by:BioMarin   based inSan Rafael, CALIFORNIA (USA)
Vimizim (elosulfase alfa) is the first approved enzyme replacement therapy designed to address the underlying cause of Morquio A syndrome, or mucopolysaccharidosis IVA (MPS IVA) — a deficiency in the enzyme N-acetylgalactosamine-6 sulfatase (GALNS). VIMIZIM works at a cellular level to help with deficient enzyme ...
CONTACT SUPPLIER

Brineura - Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 CLN2 Disease

Brineura - Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 CLN2 Disease

Manufactured by:BioMarin   based inSan Rafael, CALIFORNIA (USA)
The first approved treatment for any form of Batten disease. Brineura (cerliponase alfa) is indicated to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency. Brineura is the first enzyme replacement therapy to be directly administered into ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT